MB
Highly rated in
17
conditions
Highly rated in
17
conditions
Check Dr. Michael G. Benatar's experience treating your condition:
About Dr. Michael G. Benatar

Michael Benatar is a Neurologist in Miami, Florida. Benatar has been practicing medicine for over 30 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Spastic Paraplegia Type 7, and Paraplegia. He is licensed to treat patients in Georgia and Florida. Benatar is currently accepting new patients.

His clinical research consists of co-authoring 150 peer reviewed articles and participating in 13 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Michael G. Benatar it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Michael G. Benatar accepts the following insurance:

  •  Ambetter
  •  Bright Health
  •  Molina Healthcare
  •  Oscar
  •  UnitedHealthcare
  •  Sunshine Health
View 2 More Insurances +

Call to see if your plan is accepted.
Locations
1150 Nw 14th St, Miami, FL 33136
Background & Education
Graduate Institution
Other, 1992
Specialties
Neurology
Licenses
Psychiatry & Neurology in GA
Hospital Affiliations
Sylvester Comprehensive Cancer Center
UHealth Tower
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Phenotype, Genotype and Biomarkers 2
Clinical Procedures to Support Research in ALS (CAPTURE-ALS)
Clinical Research in Amyotrophic Lateral Sclerosis
Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis (ALS)
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
A Patient Centric Motor Neuron Disease Activities of Daily Living Scale
TRIAL READY (Clinical Trial Readiness)
A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis
View 8 Less Clinical Trials -

148 Total Publications

Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors